Koya Medical, Inc., headquartered in the United States, is a pioneering force in the medical device industry, specialising in innovative solutions for the management of chronic conditions. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced therapeutic devices, particularly in the fields of pain management and rehabilitation. Koya Medical's flagship products, which include cutting-edge neuromodulation devices, are designed to enhance patient outcomes through non-invasive treatment options. The company’s commitment to research and development has led to significant advancements in technology, setting it apart from competitors. With a strong presence across major operational regions in North America, Koya Medical continues to achieve notable milestones, solidifying its market position as a trusted provider of effective medical solutions.
How does Koya Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Koya Medical, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Koya Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Koya Medical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate commitments and reduction strategies to align with broader industry trends and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Koya Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

